Product Program year 2025 Source: CMS Open Payments

Zurzuvae

Drug Psychiatry/Psychology

NDC 64406-029-01

Open in the dashboard

General payments

$647,998

25,445 payments

Research payments

$4,819,325

68 payments

Through program year 2025, $647,998 in general payments and $4,819,325 in research payments were reported against Zurzuvae (Psychiatry/Psychology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $368,473 15,727
2025 Research $160,616 5
2024 General $279,525 9,718
2024 Research $4,658,709 63

Breakdown

Who paid General payments · program years 2024–2025
  1. Sage Therapeutics, Inc. $647,998 25,445 payments
Top recipients General payments · program year 2025
  1. Leslie Citrome Psychiatry · Pomona, NY $10,754 3% · 7 payments
  2. David Rubinow Psychiatry · Chapel Hill, NC $10,000 3% · 1 payment
  3. Catherine Birndorf Psychiatry · New York, NY $2,772 <1% · 1 payment
  4. Rachel Dalthorp Neurology · Moore, OK $2,772 <1% · 1 payment
  5. Gregory Mattingley Psychiatry · Saint Charles, MO $2,680 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Obstetrics & Gynecology $169,426 47% · 2,934 practitioners
  2. Psychiatry Psychiatry & Neurology $35,783 10% · 236 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $32,068 9% · 571 practitioners
  4. Advanced Practice Midwife $23,813 7% · 495 practitioners
  5. Nurse Practitioner, Women's Health Nurse Practitioner $20,157 6% · 388 practitioners

The top 5 of 77 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $46,780 13% · 660 recipients
  2. Texas $28,420 8% · 581 recipients
  3. Tennessee $28,235 8% · 304 recipients
  4. Pennsylvania $24,690 7% · 455 recipients
  5. Ohio $22,939 6% · 452 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

25,445 general · 68 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record